Please sign in to follow a disease.

Hormone-sensitive metastatic breast cancer

Clinical trials for Hormone-sensitive metastatic breast cancer explained in plain language.

Never miss a new study

Get alerted when new Hormone-sensitive metastatic breast cancer trials appear

Sign up with your email to follow new studies for Hormone-sensitive metastatic breast cancer, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

New radiation drug shows promise for Tough-to-Treat breast cancer

Disease control Ongoing

This early-phase trial tests a drug called RYZ101 in people with a specific type of advanced breast cancer (ER+, HER2-) that has not responded to standard treatments. The drug delivers radiation directly to cancer cells that have a certain marker (SSTR). The goal is to see if it …

Matched conditions: HORMONE-SENSITIVE METASTATIC BREAST CANCER

Phase 1/2 • Sponsor: RayzeBio, Inc. • Aim: Disease control

Last updated Aug 26, 2026 00:00 UTC

Hormone-sensitive metastatic breast cancer

Get alerted when new Hormone-sensitive metastatic breast cancer trials appear

New radiation drug shows promise for Tough-to-Treat breast cancer